医保受益人共病:ICD编码共病加权指数的表现
该研究基于健康与退休研究(HRS)2006-2016年队列中9923名社区居住的医保受益人,将共病加权指数(MWI)映射为ICD-9-CM编码版本(MWI-ICD),并与疾病计数、Charlson、Elixhauser及HRQOL-CI比较。MWI-ICD与死亡率和未来身体功能显著相关,在死亡率预测上与成熟指标相当,且能较好捕捉理赔数据中的疾病累积与功能状态。
要点
- MWI-ICD与死亡率及未来身体功能显著相关,死亡率预测与Charlson、Elixhauser相当。
- MWI-ICD分布最广、唯一值最多,左删失比例低于Charlson和Elixhauser。
- MWI-ICD并非按死亡率加权,但预测表现与成熟指标 comparable。
核心结论
- MWI-ICD与死亡率及未来身体功能显著相关,且在死亡率预测上与成熟指标相当,尽管并非按死亡率加权。
- MWI-ICD能成功捕捉理赔数据中的疾病累积和功能状态。
研究设计与样本
- 基于人群的前瞻性队列研究,对象为2006-2016年HRS受访者中链接医保理赔数据且2006年连续参保者。
- 样本为9923名社区居住的医保合格HRS参与者,平均年龄75.5±8.5岁。
- 随访未来身体功能(2006-2014)和死亡率(2007-2016)。
主要发现
- MWI-ICD分布最广、唯一值最多(5891个)。
- 左删失最明显的是Charlson(34.3%评分为0)和Elixhauser(13.1%评分为0),而MWI为5.0%评分为0。
- 极端四分位间死亡风险比和一致性(C)统计量在MWI-ICD、Elixhauser和Charlson间相似,但疾病计数和HRQOL-CI较低。
- 对于身体功能,MWI-ICD在极端四分位间产生最大对比及总体决定系数(R2)。
关键数值与推荐
- MWI-ICD左删失比例5.0%评分为0,Charlson为34.3%评分为0,Elixhauser为13.1%评分为0。
- MWI-ICD唯一值数量为5891。
临床怎么用
- 在老年医保理赔数据中,可用MWI-ICD量化共病累积及功能状态,辅助死亡风险分层。
- MWI-ICD在死亡率预测上与Charlson、Elixhauser相当,可作为共病评估的替代工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Most older adults have multimorbidity that impairs physical functioning, but it is difficult to quantify using claims data. We previously developed and validated a multimorbidity-weighted index (MWI) that embeds physical functioning through disease weightings. We mapped these conditions to International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes and compared them with existing indices. DESIGN: Population-based prospective cohort. SETTING: Respondents to the 2006-2016 waves of the Health and Retirement Study (HRS) with linked Medicare claims data and continuous enrollment in 2006. PARTICIPANTS: Community-dwelling Medicare-eligible HRS participants (N = 9923; mean age = 75.5 ± 8.5 y). MEASUREMENTS: Individuals were followed for future physical functioning (2006-2014) and mortality (2007-2016). MWI conditions were mapped to ICD-9-CM codes to produce an ICD-coded MWI (MWI-ICD). We compared MWI-ICD, simple disease count, Charlson, Elixhauser, and the health-related quality of life comorbidity index (HRQOL-CI) through distributions, hazard ratios for mortality, and relationships with future physical functioning. RESULTS: MWI-ICD exhibited the broadest distribution and most unique values (5891). Left censoring was most pronounced for Charlson (34.3% score = 0) and Elixhauser (13.1% score = 0) vs MWI (5.0% score = 0). Hazard ratios and concordance (C)-statistics for mortality across extreme quartiles were similar for MWI-ICD, Elixhauser, and Charlson but lower for disease count and the HRQOL-CI. For physical functioning, MWI-ICD yielded the greatest contrast across extreme quartiles and overall coefficient of determination (R2 ). CONCLUSION: MWI-ICD was significantly associated with mortality and future physical functioning and comparable with established metrics for mortality prediction although not weighted to mortality. MWI-ICD successfully captures diseases accumulation and functioning in claims data. J Am Geriatr Soc 68:999-1006, 2020.
引用
- Wei MY, Ratz D, Mukamal KJ, et al. Multimorbidity in Medicare Beneficiaries: Performance of an ICD-Coded Multimorbidity-Weighted Index. J Am Geriatr Soc. 2020. PMID: 31917465. doi:10.1111/jgs.16310
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。